During the past decade, Kern County Neurological Medical Group, INC. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kern County Neurological Medical Group, INC." #1 collaborator was "Sunovion" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kern County Neurological Medical Group, INC." are "Epilepsy" (1 trials) and "Partial Epilepsy" (1 trials). Many other conditions were trialed in "Kern County Neurological Medical Group, INC." in a lesser frequency.

Most popular intervention types in "Kern County Neurological Medical Group, INC." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "1200 mg QD Eslicarbazepine acetate" (1 trials), "800 mg QD Eslicarbazepine acetate" (1 trials), "Eslicarbazepine acetate 1200 mg" (1 trials), "Eslicarbazepine acetate 1600 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kern County Neurological Medical Group, INC." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kern County Neurological Medical Group, INC.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kern County Neurological Medical Group, INC., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kern County Neurological Medical Group, INC., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".